Australian Red Cross Blood Service[Corporate Author] - Search Results

Year	Number of Results
2002	1
2003	2
2004	1
2007	2
2008	1
2014	1
2024	0

1

Validation and assessment of a blood-donor arm disinfectant containing chlorhexidine and alcohol.

Wong PY, Colville VL, White V, Walker HM, Morris RA; Microbial Contamination and Infection Control Subcommittee, Australian Red Cross Blood Service. Wong PY, et al. Transfusion. 2004 Aug;44(8):1238-42. doi: 10.1111/j.1537-2995.2004.03362.x. Transfusion. 2004. PMID: 15265130

2

Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.

Kiely P, Margaritis AR, Seed CR, Yang H; Australian Red Cross Blood Service NAT Study Group. Kiely P, et al. Transfusion. 2014 Aug;54(8):2084-91. doi: 10.1111/trf.12556. Epub 2014 Mar 20. Transfusion. 2014. PMID: 24650170

3

Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies.

Mison L, Seed CR, Margaritis AR, Hyland C; Australian Red Cross Blood Service Nucleic Acid Technology Study Group. Mison L, et al. Vox Sang. 2003 Jan;84(1):11-9. doi: 10.1046/j.1423-0410.2003.00246.x. Vox Sang. 2003. PMID: 12542729

4

Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006.

Polizzotto MN, Wood EM, Ingham H, Keller AJ; Australian Red Cross Blood Service Donor and Product Safety Team. Polizzotto MN, et al. Transfusion. 2008 Jan;48(1):55-63. doi: 10.1111/j.1537-2995.2007.01482.x. Epub 2007 Sep 24. Transfusion. 2008. PMID: 17894794

5

Saline or albumin for fluid resuscitation in patients with traumatic brain injury.

SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian Red Cross Blood Service; George Institute for International Health; Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N, Kai Lo S, Vallance S. SAFE Study Investigators, et al. N Engl J Med. 2007 Aug 30;357(9):874-84. doi: 10.1056/NEJMoa067514. N Engl J Med. 2007. PMID: 17761591 Free article. Clinical Trial.

6

Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays.

Seed CR, Margaritis AR, Bolton WV, Kiely P, Parker S, Piscitelli L; Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service. Seed CR, et al. Transfusion. 2003 Feb;43(2):226-34. doi: 10.1046/j.1537-2995.2003.00304.x. Transfusion. 2003. PMID: 12559018

7

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

Seed CR, Cheng A, Ismay SL, Bolton WV, Kiely P, Cobain TJ, Keller AJ; Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service. Seed CR, et al. Transfusion. 2002 Oct;42(10):1365-72. doi: 10.1046/j.1537-2995.2002.00204.x. Transfusion. 2002. PMID: 12423522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year